Subclade K Fuels Rising U.S. Flu Cases, Vaccination Urged
A mutated H3N2 subclade K is driving a rapid U.S. flu rise, doubling hospitalizations; officials urge vaccination, testing and antivirals to protect vulnerable populations now.
Boston HeraldFlu is rising rapidly, driven by a new variant. Here’s what to know
USA TODAYFlu cases are rising in 32 states. Check maps and see how to stay safe
TIME MagazineFlu Cases Are Skyrocketing in the U.S.
NPRWhy flu cases are surging this season. And, protests erupt in Iran over the economy
Overview
CDC reports at least 7.5 million cases, 81,000 hospitalizations and 3,100 deaths since October; New York alone saw 71,000 cases in one week ending Dec. 20.
Subclade K, a mutated H3N2 first noted in the UK, Japan and Canada, is now dominant across the U.S. during a season that typically starts in December.
This season's vaccine was developed before subclade K emerged; U.K. analysis shows partial protection against hospitalization, and matches well against H1N1 and Type B strains.
CDC and medical societies recommend vaccination for everyone six months and older; only about 42% of people are vaccinated, and antivirals are advised for high-risk patients.
At least eight child deaths were reported as of Dec. 20; FluMist nasal spray now available for ages 2–49, with eligible people allowed to self-administer at home this year.
Analysis
Center-leaning sources frame the flu surge story with a focus on public health and safety, emphasizing the importance of vaccination and preventive measures. Language choices highlight the severity of the situation with terms like "surge," "spike," and "super flu." Source selection prioritizes expert opinions from health officials and doctors, underscoring the need for vaccinations and hygiene practices. Structural choices present a balanced view by including data, expert insights, and practical advice, creating a narrative that encourages informed action without inducing panic.